Drug Discovery App CS WP
-
Transfer Of Fed-Batch To Semi-Perfusion Process
4/14/2025
Continuous processes enhance product quality, yield, and cost savings. Explore transitioning a fed-batch process to perfusion using a small batch bioreactor system to optimize cell culture conditions and comparing performances.
-
Improve Productivity And Reduce Risk With Biostat® RM
4/14/2025
Discover how a company overcame cell generation challenges by using a system that achieves a seed ratio of 1:120 and saves four days in seed preparation time.
-
Extractables And Leachables Assessment For Single-Use Systems
4/14/2025
Efforts to enhance biopharmaceutical manufacturing focus on boosting production capacity sustainably and economically. Explore how optimizing processes with single-use solutions and monitoring leachables ensures product quality.
-
Downstream Processing Of A Mid-Scale Lentiviral Vector Batch
4/4/2025
Explore how tangential flow filtration (TFF) systems streamline lentivirus purification to enhance efficiency and scalability in CAR-T cell production, which is a crucial advancement in cancer immunotherapy.
-
Assuring Multipotency Of Human Mesenchymal Stem Cells (hMSCs)
4/4/2025
Stem cell research has revolutionized tissue repair and regenerative medicine. Discover how mesenchymal stem cells play a key role and offer insights into connective tissue repair, immune response, and inflammatory diseases.
-
2D To 3D Transition Of Mesenchymal Stem Cell Expansion Process
4/4/2025
Discover how transitioning from 2D to 3D culture methods enhances the scalability, yield, and quality of Mesenchymal Stem Cells (MSCs) for therapeutic applications to address critical manufacturing challenges.
-
Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines
3/24/2025
Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.
-
Enhance Your Downstream T-Cell Processing
3/4/2025
T-cell therapies, including CAR-T and TCR, revolutionize cancer treatment by harnessing the immune system. Explore an efficient and scalable production process that helps meet crucial demand.
-
Streamlining Compliance With Pre-Clinical Safety Tests
3/4/2025
As cell therapies advance, challenges in ensuring safe, scalable, and compliant production increase. Discover how to develop efficient strategies to maintain cell viability and functionality throughout the supply chain.
-
A Cost-Effective Alternative To Traditional Protein A Resin Chromatography
2/6/2025
Examine this cost-effective, efficient alternative to traditional Protein A resin chromatography for mAb production to enhance productivity and reduce costs.